| 000 | 01376 a2200337 4500 | ||
|---|---|---|---|
| 005 | 20250514223824.0 | ||
| 264 | 0 | _c20051110 | |
| 008 | 200511s 0 0 ger d | ||
| 022 | _a1436-9990 | ||
| 024 | 7 |
_a10.1007/s00103-005-1015-8 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHeidenreich, K | |
| 245 | 0 | 0 |
_a[Clinical trials in Germany and in the EU in the new legislative environment. An analysis from the industry's point of view]. _h[electronic resource] |
| 260 |
_bBundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz _cApr 2005 |
||
| 300 |
_a415-22 p. _bdigital |
||
| 500 | _aPublication Type: English Abstract; Journal Article | ||
| 650 | 0 | 4 |
_aClinical Trials as Topic _xlegislation & jurisprudence |
| 650 | 0 | 4 |
_aDrug Approval _xlegislation & jurisprudence |
| 650 | 0 | 4 | _aDrug-Related Side Effects and Adverse Reactions |
| 650 | 0 | 4 | _aEuropean Union |
| 650 | 0 | 4 | _aGermany |
| 650 | 0 | 4 | _aGuidelines as Topic |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMulticenter Studies as Topic |
| 650 | 0 | 4 |
_aQuality Assurance, Health Care _xlegislation & jurisprudence |
| 700 | 1 | _aMöritz, A | |
| 700 | 1 | _aLöffler, H | |
| 700 | 1 | _aOberle-Rolle, B | |
| 773 | 0 |
_tBundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz _gvol. 48 _gno. 4 _gp. 415-22 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s00103-005-1015-8 _zAvailable from publisher's website |
| 999 |
_c15498814 _d15498814 |
||